[go: up one dir, main page]

EP1075184A4 - COMPOSITIONS AND METHODS FOR ACTIVE Vaccination - Google Patents

COMPOSITIONS AND METHODS FOR ACTIVE Vaccination

Info

Publication number
EP1075184A4
EP1075184A4 EP99921790A EP99921790A EP1075184A4 EP 1075184 A4 EP1075184 A4 EP 1075184A4 EP 99921790 A EP99921790 A EP 99921790A EP 99921790 A EP99921790 A EP 99921790A EP 1075184 A4 EP1075184 A4 EP 1075184A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
active vaccination
vaccination
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99921790A
Other languages
German (de)
French (fr)
Other versions
EP1075184A1 (en
Inventor
David B Agus
David Scheinberg
Wendy Roberts
Andrew D Zelenetz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Sloan Kettering Cancer Center filed Critical Memorial Sloan Kettering Cancer Center
Publication of EP1075184A1 publication Critical patent/EP1075184A1/en
Publication of EP1075184A4 publication Critical patent/EP1075184A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001103—Receptors for growth factors
    • A61K39/001104—Epidermal growth factor receptors [EGFR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001103—Receptors for growth factors
    • A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001103—Receptors for growth factors
    • A61K39/001109—Vascular endothelial growth factor receptors [VEGFR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001111—Immunoglobulin superfamily
    • A61K39/001112—CD19 or B4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001116—Receptors for cytokines
    • A61K39/001119—Receptors for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001124—CD20
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EP99921790A 1998-05-08 1999-05-07 COMPOSITIONS AND METHODS FOR ACTIVE Vaccination Withdrawn EP1075184A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8487098P 1998-05-08 1998-05-08
US84870P 1998-05-08
PCT/US1999/010065 WO1999057981A1 (en) 1998-05-08 1999-05-07 Compositions and methods for active vaccination

Publications (2)

Publication Number Publication Date
EP1075184A1 EP1075184A1 (en) 2001-02-14
EP1075184A4 true EP1075184A4 (en) 2002-01-30

Family

ID=22187732

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99921790A Withdrawn EP1075184A4 (en) 1998-05-08 1999-05-07 COMPOSITIONS AND METHODS FOR ACTIVE Vaccination

Country Status (4)

Country Link
EP (1) EP1075184A4 (en)
JP (1) JP2002514573A (en)
CA (1) CA2330212A1 (en)
WO (1) WO1999057981A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7198920B1 (en) 1999-01-29 2007-04-03 Corika Corporation HER-2/neu fusion proteins
AU2001252262B2 (en) 2000-04-13 2006-02-02 Biolife Science Forschungs-und Entwicklungsgesellschaft m.b.H Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
US7229623B1 (en) 2000-08-03 2007-06-12 Corixa Corporation Her-2/neu fusion proteins
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
BR0113235A (en) * 2000-08-14 2004-06-08 Corixa Corp Compositions and methods for therapy and diagnosis of her-2 / neu-associated malignancies
CU22979A1 (en) * 2000-12-08 2004-09-09 Centro Inmunologia Molecular IMMUNOTHERAPEUTIC COMBINATION FOR THE TREATMENT OF TUMORS OVER-EXPRESSING RECEPTORS WITH KINASE ACTIVITY IN TYPOSINE WASTE
ES2394293T3 (en) * 2001-02-28 2013-01-30 Bio Life Science Forschungs- Und Entwicklungsges.M.B.H. Vaccine against cancers that are associated with the HER-2 / neu oncogene
CU23178A1 (en) * 2002-04-15 2006-09-22 Ct Ingenieria Genetica Biotech ANTIANGIOGEN ACTIVE ACTIVE IMMUNOTHERAPY
FR2844514B1 (en) 2002-09-16 2007-10-19 Neovacs STABLE IMMUNOGENIC PRODUCT COMPRISING ANTIGENIC HETEROCOMPLEXES, COMPOSITIONS CONTAINING SAME, AND PREPARATION METHOD
JP2006516258A (en) * 2002-12-27 2006-06-29 シェンジェンシチンファユアンシンシェンウイヤオカジヨウシャンゴンシ Methods for preparing vaccines and anti-tumor vaccines
WO2005007673A2 (en) * 2003-07-03 2005-01-27 Rush University Medical Center Immunogenic peptides
WO2005067980A2 (en) * 2004-01-12 2005-07-28 Pointilliste, Inc. Design of therapeutics and therapeutics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US5550214A (en) * 1994-02-10 1996-08-27 Brigham And Women's Hospital Isolated antigenic oncogene peptide fragments and uses

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE PUBMED [online] NCBI; 5 May 2004 (2004-05-05), PARRY ET AL: "Identification of MUC1 proteolytic cleavage sites in vivo" *
See also references of WO9957981A1 *
SHAN DAMING ET AL: "Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies.", BLOOD, vol. 91, no. 5, 1 March 1998 (1998-03-01), pages 1644 - 1652, XP002182861, ISSN: 0006-4971 *
ZHANG SHENGLE ET AL: "Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice.", CANCER RESEARCH, vol. 56, no. 14, 1996, pages 3315 - 3319, XP002097413, ISSN: 0008-5472 *

Also Published As

Publication number Publication date
CA2330212A1 (en) 1999-11-18
EP1075184A1 (en) 2001-02-14
JP2002514573A (en) 2002-05-21
WO1999057981A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
DE60003250D1 (en) Cleaning compositions and cleaning methods
DE60011391D1 (en) METHOD AND COMPOSITIONS FOR INCREASING THE NUMBER OF WHITE BLOOD CELLS
EP1227821A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD FOR USE THEREOF
DE69831358D1 (en) SYSTEM AND METHOD FOR SIMPLIFICATION OF THE FARMING
DE60017955D1 (en) METHOD AND COMPOSITIONS FOR PEPTIDE SYNTHESIS
DE60140895D1 (en) COMPOSITION AND METHOD
DE60018907D1 (en) METHOD AND COMPOSITION FOR CEMENTING HOUSING
DE60116447D1 (en) Method and system for connection treatment
DE69820997D1 (en) COMPOSITIONS AND METHODS FOR TREATING THE INCREASED EYES PRINTOUT
ATE277621T1 (en) METHODS AND COMPOSITIONS FOR PREVENTING BRONCHODILATOR TOLERANCE
ATE351910T1 (en) COMPOSITIONS AND METHODS CONTAINING OB-FUSION PROTEIN
DE60116484D1 (en) COPOLYMERS FOR PHOTORESISTIC COMPOSITIONS AND METHOD FOR THE PREPARATION THEREOF
DE10083668T1 (en) Bone cement mixer and method
DE60042883D1 (en) COMPOSITIONS AND METHODS OF MODIFYING THE TRANSFORMATION
DE69534416D1 (en) METHOD AND FORMULATIONS FOR COMBATING DAMAGES
ATE271598T1 (en) DISINFECTANT COMPOSITIONS AND METHODS
DE69822873D1 (en) COMPOSITIONS AND METHODS FOR WEIGHT REDUCTION
EP1088333A4 (en) METHOD AND COMPOSITIONS FOR CONNECTING OSTEOPROSIS
ATE201557T1 (en) METHOD FOR SOIL STERILIZATION AND ASSOCIATED ARRANGEMENT
DE69935193D1 (en) Tomographic procedure and system
EP1129217A4 (en) COMPOSITIONS AND METHODS FOR SICKNESS DIAGNOSIS AND THERAPY
DE60121896D1 (en) Method and system for mixing silicone compositions
DE69602847D1 (en) TUBERKILICIDE SYNERGISTIC DISINFECTING COMPOSITION AND METHOD FOR DISINFECTING
DE69912254D1 (en) COSMETIC METHOD FOR TREATMENT
DE60016639D1 (en) Method and device for pathfinding

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001204

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE DK ES FR GB IT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 01N 37/18 A, 7A 61K 39/00 B, 7A 61K 39/385 B, 7A 61P 35/00 B, 7C 07K 14/705 -

A4 Supplementary search report drawn up and despatched

Effective date: 20011218

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE DK ES FR GB IT SE

17Q First examination report despatched

Effective date: 20020927

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RTI1 Title (correction)

Free format text: METHOD FOR ACTIVE VACCINATION AGASINT CD20

RTI1 Title (correction)

Free format text: METHOD FOR ACTIVE VACCINATION AGAINST CD20

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061201